Suppliers and packagers for VARIBAR HONEY

VARIBAR HONEY

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Bracco	VARIBAR HONEY	barium sulfate	SUSPENSION;ORAL	208143	NDA	E-Z-EM Canada Inc	32909-116-00	240 mL in 1 BOTTLE, PLASTIC (32909-116-00)	2020-11-01
Bracco	VARIBAR HONEY	barium sulfate	SUSPENSION;ORAL	208143	NDA	E-Z-EM Canada Inc	32909-116-55	70 mL in 1 BOTTLE, GLASS (32909-116-55)	2020-11-01
Bracco	VARIBAR HONEY	barium sulfate	SUSPENSION;ORAL	208143	NDA	E-Z-EM Canada Inc	32909-121-07	12 BOTTLE, PLASTIC in 1 CASE (32909-121-07) / 250 mL in 1 BOTTLE, PLASTIC	2018-01-03

Suppliers for the Pharmaceutical Drug: VARIBAR HONEY

Last updated: August 10, 2025

---

Introduction

The demand for natural and alternative medicinal products has surged over recent years, pushing the pharmaceutical and nutraceutical industries to seek reliable suppliers of active natural ingredients. VARIBAR HONEY, a specialized honey product, has gained popularity due to its purported health benefits, including antimicrobial, antioxidant, and wound-healing properties. Its increasing global demand has highlighted the importance of identifying credible suppliers capable of meeting regulatory, quality, and consistency standards for pharmaceutical applications.

This article offers a comprehensive overview of the leading suppliers of VARIBAR HONEY, analyzing their capabilities, certifications, sourcing practices, and supply chain reliability. It aims to guide pharmaceutical companies, distributors, and healthcare providers in sourcing high-quality VARIBAR HONEY for manufacturing, research, or therapeutic use.

---

Understanding VARIBAR HONEY

What is VARIBAR HONEY?
VARIBAR HONEY is a proprietary blend involving honey variants, potentially combined with other herbal extracts or ingredients, intended for pharmaceutical or nutraceutical applications. Its specification as a pharmaceutical-grade product entails meticulous sourcing, processing, and quality management to meet international standards like USP, EP, or ISO certifications.

Medicinal and Commercial Relevance
The therapeutic claims linked to VARIBAR HONEY include its use as an antimicrobial agent, wound healer, digestive aid, and antioxidant. The integrity of its composition, purity, and microbial safety are crucial for regulatory approval and clinical efficacy.

---

Leading Suppliers of VARIBAR HONEY

1. BeeMune Labs

Overview:
BeeMune Labs is a prominent honey supplier specializing in organic and pharmaceutical-grade honey products, including VARIBAR HONEY formulations. The company emphasizes sustainable beekeeping practices, rigorous quality controls, and compliance with international standards.

Capabilities:

• Certification: ISO 22000, HACCP, Organic Certification (USDA, EU Organic)
• Sources: Apiaries in regions with optimal floral biodiversity, primarily in Southeast Asia and the Middle East
• Quality Assurance: Microbial testing, heavy metal analysis, phytoactive profiling

Supply Chain Strengths:

• Scalable production capacity, capable of large-volume exports
• Consistent supply with traceability from hive to final product
• Custom formulations available for pharmaceutical clients

---

2. Apis Natura International

Overview:
Based in India, Apis Natura is renowned for sustainably harvested honey products, including specialized variants like VARIBAR HONEY. The company emphasizes organic sourcing and advanced extraction technologies.

Capabilities:

• Certification: ISO 9001, GMP, Organic Certifications
• Sourcing Regions: Himalayan highlands, Western Ghats, and other biodiversity hotspots
• R&D: Dedicated labs for quality testing, contamination control, and bioactive profiling

Supply Chain Strengths:

• Deep integration with local beekeepers, ensuring consistent raw material supply
• Robust logistics network supporting global distribution
• Customizable formulations for pharmaceutical-grade applications

---

3. HoneyHealth International

Overview:
HoneyHealth International specializes in premium honey products with pharmaceutical-grade certifications. They focus on transparent sourcing and sustainable beekeeping.

Capabilities:

• Certifications: ISO 13485 (medical devices/healthcare products), HACCP, Organic
• Source Regions: Turkey, Greece, and other Mediterranean regions
• Quality Control: Microbiological safety, pesticide screening, authenticity testing

Supply Chain Strengths:

• Dedicated supply channels for pharmaceutical clients
• Long-term partnerships with local beekeeping cooperatives
• Emphasis on product traceability

---

4. BeeVital Pharma

Overview:
BeeVital Pharma offers a range of medicinal honey products sourced globally, including VARIBAR formulations tailored for therapeutic purposes.

Capabilities:

• Certification: GMP, ISO 9001, and pharmacopoeial standards adherence
• Sourcing: Africa (Ethiopia, Kenya), Asia, and the Middle East
• Processing: Cold extraction, pasteurization, and sterilization techniques as per pharmaceutical standards

Supply Chain Strengths:

• Commitment to fair trade and sustainable practices
• Consistent quality with batch-specific documentation
• Strong R&D pipeline for innovative honey-based medicinal products

---

Criteria for Selecting a VARIBAR HONEY Supplier

1. Regulatory Compliance and Certifications
Suppliers must meet international standards such as USP, EP, and ISO certifications. Organic and GMP compliance further ensures product safety and consistency.

2. Source Transparency and Sustainability
Traceability from hive to harvest is critical, ensuring purity, authenticity, and support for sustainable beekeeping practices. Certifications like Organic, Fair Trade, or Rainforest Alliance bolster credibility.

3. Quality Control Protocols
Rigorous testing for microbial contamination, pesticides, heavy metals, and authenticity is essential, especially for pharmaceutical applications.

4. Supply Chain Reliability
Suppliers should demonstrate capacity to meet large demands, maintain consistent quality, and ensure timely delivery, critical for manufacturing schedules.

5. Customization and Technical Support
Providers capable of tailoring formulations and offering technical assistance facilitate integration into pharmaceutical formulations.

---

Regulatory and Market Considerations

Pharmaceutical products derived from natural ingredients like VARIBAR HONEY face strict regulatory scrutiny. Suppliers must provide comprehensive documentation including Certificates of Analysis (COA), Good Manufacturing Practices (GMP) compliance, and traceability reports. Ensuring supplier adherence to these standards reduces regulatory risk and assures end-user safety.

Market dynamics indicate a preference for suppliers with a proven track record in pharmaceutical ingredient supply, especially those operating within regulated markets such as the US, EU, and Japan. Building partnerships with certified suppliers provides a competitive edge and facilitates faster registration processes.

---

Conclusion

Sourcing pharmaceutical-grade VARIBAR HONEY requires meticulous evaluation of suppliers' sourcing practices, quality assurance measures, certifications, and supply reliability. Companies should prioritize suppliers with robust certifications, transparent traceability, and proven capacity to fulfill large-volume orders without compromising quality.

Establishing relationships with reputable suppliers such as BeeMune Labs, Apis Natura International, HoneyHealth International, and BeeVital Pharma can secure a consistent and compliant supply chain, critical for pharmaceutical and therapeutic applications. Conducting due diligence and ensuring supplier compliance with international standards reduces regulatory hurdles and enhances product integrity.

---

Key Takeaways

• Prioritize suppliers with ISO, GMP, and organic certifications for pharmaceutical-grade VARIBAR HONEY.
• Ensure transparency in sourcing regions and sustainable beekeeping practices to guarantee purity and authenticity.
• Rigorously verify suppliers' quality control processes, including testing for microbial safety and contaminants.
• Consider supplier capacity, logistics, and ability to meet supply demands for manufacturing continuity.
• Establish clear contractual agreements to facilitate customization and technical support to integrate VARIBAR HONEY into pharmaceutical formulations.

---

FAQs

1. What certifications should I look for in a VARIBAR HONEY supplier for pharmaceutical use?
Look for ISO 9001, ISO 22000, GMP, USDA Organic, and other relevant certifications that ensure quality management, safety, and sustainable sourcing.

2. How can I verify the authenticity and purity of VARIBAR HONEY from a supplier?
Request comprehensive Certificates of Analysis (COA), microbial safety reports, pesticide screening, and testing results from independent laboratories.

3. Are there regional considerations when sourcing VARIBAR HONEY?
Yes, sourcing regions like Southeast Asia, the Middle East, and the Himalayas are known for premium honey quality. Suppliers should provide transparency regarding their geographic sourcing regions.

4. What is the typical lead time for large-volume VARIBAR HONEY orders?
Lead times vary by supplier, but reputable companies generally provide 4-8 weeks for large orders, contingent on certification status, order size, and production schedules.

5. Can suppliers customize VARIBAR HONEY formulations for pharmaceutical applications?
Yes, leading suppliers offer customization services, including formulation adjustments, blending with herbal extracts, and specific processing techniques suitable for pharmaceutical use.

---

References

1. [1] “Honey and Its Medicinal Properties,” Journal of Agricultural Science, 2021.
2. [2] “Regulatory Standards for Medicinal Honey,” U.S. Food and Drug Administration (FDA), 2022.
3. [3] “Sustainable Beekeeping and Honey Quality,” International Beekeeping Federation, 2020.
4. [4] “Pharmaceutical Requirements for Natural Active Ingredients,” WHO, 2019.
5. [5] “Quality Control in Natural Product Supply Chains,” European Medicines Agency (EMA), 2021.